Join our daily newsletter At The Bell to receive exclusive market insights
The ASX has been trading flat at around 7,864 points.
Financials has been the best performing sector, up 0.3%, followed by Materials, up 0.15% and Energy, up 0.1%.
Utilities has been the worst performer, down 1.1%, followed by Industrials and Staples, both down 0.55%.
Opthea (ASX:OPT) has been the most watched on HotCopper forums today. The company is in a voluntary suspension pending the release of top line results of its COAST clinical trial.
Also trending Imugene (ASX:IMU) has revealed the US Food and Drug Administration has granted Fast Track Designation to its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel), for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Rounding out the most discussed is Arizona Lithium (ASX:AZL) after kicking off a share purchase plan to raise $2 million to advance the Prairie project.
You’re up to date, see you later for market close.
